| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 1.86e-06 | 4 | 156 | 3 | GO:0047696 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP8B3 MYH1 MYH2 MYH8 HYOU1 DYNC2H1 CFTR RNF213 DNAH7 ATP10D KIF20A BLM ABCA6 ABCE1 ERCC6L2 SMC1B ACSS3 | 6.53e-06 | 614 | 156 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | ethanol binding | 9.20e-06 | 6 | 156 | 3 | GO:0035276 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 1.60e-05 | 7 | 156 | 3 | GO:0004703 | |
| GeneOntologyMolecularFunction | bubble DNA binding | 2.55e-05 | 8 | 156 | 3 | GO:0000405 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.96e-05 | 118 | 156 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TRPM6 GAK RPS6KA5 GRK5 WNK1 MYLK2 TLK1 GRK2 GRK3 PIK3CG PRKCA OXSR1 EIF2AK1 | 4.99e-05 | 446 | 156 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP8B3 MYH8 DYNC2H1 CFTR RNF213 DNAH7 ATP10D KIF20A BLM ABCA6 ABCE1 SMC1B | 1.86e-04 | 441 | 156 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | protein kinase activity | TRPM6 GAK ABL1 RPS6KA5 GRK5 WNK1 MYLK2 TLK1 GRK2 GRK3 PIK3CG PRKCA OXSR1 EIF2AK1 | 2.67e-04 | 600 | 156 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 2.90e-04 | 41 | 156 | 4 | GO:0000217 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP8B3 NUGGC MYH8 DYNC2H1 RNF112 CFTR TRPM2 RNF213 DNAH7 ATP10D KIF20A BLM ABCA6 ABCE1 ASMTL RHOF SMC1B | 3.10e-04 | 839 | 156 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP8B3 NUGGC MYH8 DYNC2H1 RNF112 CFTR TRPM2 RNF213 DNAH7 ATP10D KIF20A BLM ABCA6 ABCE1 ASMTL RHOF SMC1B | 3.14e-04 | 840 | 156 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP8B3 NUGGC MYH8 DYNC2H1 RNF112 CFTR TRPM2 RNF213 DNAH7 ATP10D KIF20A BLM ABCA6 ABCE1 ASMTL RHOF SMC1B | 3.14e-04 | 840 | 156 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TRPM6 GAK ABL1 RPS6KA5 GRK5 DGKD WNK1 MYLK2 TLK1 GRK2 GRK3 PIK3CG PRKCA OXSR1 EIF2AK1 | 4.54e-04 | 709 | 156 | 15 | GO:0016773 |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 8.39e-04 | 24 | 156 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | kinase activity | TRPM6 GAK ABL1 RPS6KA5 GRK5 DGKD WNK1 MYLK2 TLK1 GRK2 GRK3 PIK3CG PRKCA OXSR1 EIF2AK1 | 9.74e-04 | 764 | 156 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.07e-03 | 26 | 156 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP8B3 NUGGC MYH8 DYNC2H1 RNF112 CFTR RNF213 DNAH7 ATP10D KIF20A BLM ABCA6 ABCE1 RHOF SMC1B | 1.12e-03 | 775 | 156 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.63e-03 | 30 | 156 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | myosin light chain binding | 1.65e-03 | 8 | 156 | 2 | GO:0032027 | |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 4.24e-07 | 3 | 156 | 3 | GO:0046186 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 4.20e-06 | 5 | 156 | 3 | GO:0006117 | |
| MousePheno | abnormal ethanol metabolism | 1.18e-05 | 6 | 119 | 3 | MP:0005443 | |
| MousePheno | abnormal retinol metabolism | 2.05e-05 | 7 | 119 | 3 | MP:0005444 | |
| Domain | GPCR_kinase | 1.77e-05 | 7 | 151 | 3 | IPR000239 | |
| Domain | ADH_Zn_CS | 2.82e-05 | 8 | 151 | 3 | IPR002328 | |
| Domain | ADH_ZINC | 2.82e-05 | 8 | 151 | 3 | PS00059 | |
| Domain | P-loop_NTPase | MYH1 MYH2 NUGGC MYH8 DYNC2H1 RNF112 CFTR RNF213 DNAH7 KIF20A BLM NLRP14 ABCA6 ABCE1 ERCC6L2 RHOF MYO16 SMC1B NLRP13 | 5.55e-05 | 848 | 151 | 19 | IPR027417 |
| Domain | AGC-kinase_C | 8.86e-05 | 56 | 151 | 5 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 8.86e-05 | 56 | 151 | 5 | PS51285 | |
| Domain | S_TK_X | 8.86e-05 | 56 | 151 | 5 | SM00133 | |
| Domain | Kinase-like_dom | TRPM6 GAK ABL1 RPS6KA5 GRK5 WNK1 MYLK2 TLK1 GRK2 GRK3 PIK3CG PRKCA OXSR1 EIF2AK1 | 1.32e-04 | 542 | 151 | 14 | IPR011009 |
| Domain | Ser/Thr_kinase_AS | GAK RPS6KA5 GRK5 WNK1 MYLK2 TLK1 GRK2 GRK3 PRKCA OXSR1 EIF2AK1 | 1.58e-04 | 357 | 151 | 11 | IPR008271 |
| Domain | S_TKc | GAK RPS6KA5 GRK5 WNK1 MYLK2 TLK1 GRK2 GRK3 PRKCA OXSR1 EIF2AK1 | 1.66e-04 | 359 | 151 | 11 | SM00220 |
| Domain | PROTEIN_KINASE_ST | GAK RPS6KA5 GRK5 WNK1 MYLK2 TLK1 GRK2 GRK3 PRKCA OXSR1 EIF2AK1 | 1.78e-04 | 362 | 151 | 11 | PS00108 |
| Domain | Ribosomal_L3 | 1.94e-04 | 3 | 151 | 2 | IPR000597 | |
| Domain | RIBOSOMAL_L3 | 1.94e-04 | 3 | 151 | 2 | PS00474 | |
| Domain | Ribosomal_L3 | 1.94e-04 | 3 | 151 | 2 | PF00297 | |
| Domain | Ribosomal_L3_CS | 1.94e-04 | 3 | 151 | 2 | IPR019926 | |
| Domain | Myosin_N | 2.19e-04 | 15 | 151 | 3 | PF02736 | |
| Domain | Myosin_N | 2.19e-04 | 15 | 151 | 3 | IPR004009 | |
| Domain | Myosin_head_motor_dom | 2.45e-04 | 38 | 151 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.45e-04 | 38 | 151 | 4 | PS51456 | |
| Domain | Myosin_head | 2.45e-04 | 38 | 151 | 4 | PF00063 | |
| Domain | MYSc | 2.45e-04 | 38 | 151 | 4 | SM00242 | |
| Domain | PKS_ER | 2.69e-04 | 16 | 151 | 3 | IPR020843 | |
| Domain | ADH_N | 2.69e-04 | 16 | 151 | 3 | PF08240 | |
| Domain | PKS_ER | 2.69e-04 | 16 | 151 | 3 | SM00829 | |
| Domain | ADH_N | 2.69e-04 | 16 | 151 | 3 | IPR013154 | |
| Domain | Pkinase | GAK RPS6KA5 GRK5 WNK1 MYLK2 TLK1 GRK2 GRK3 PRKCA OXSR1 EIF2AK1 | 2.77e-04 | 381 | 151 | 11 | PF00069 |
| Domain | PROTEIN_KINASE_ATP | GAK ABL1 RPS6KA5 GRK5 WNK1 MYLK2 TLK1 GRK2 GRK3 PRKCA OXSR1 EIF2AK1 | 3.61e-04 | 459 | 151 | 12 | PS00107 |
| Domain | DUF1394 | 3.85e-04 | 4 | 151 | 2 | IPR009828 | |
| Domain | DUF1394 | 3.85e-04 | 4 | 151 | 2 | PF07159 | |
| Domain | - | 3.87e-04 | 18 | 151 | 3 | 3.90.180.10 | |
| Domain | Myosin_tail_1 | 3.87e-04 | 18 | 151 | 3 | PF01576 | |
| Domain | Myosin_tail | 3.87e-04 | 18 | 151 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 4.56e-04 | 19 | 151 | 3 | IPR027401 | |
| Domain | - | 4.56e-04 | 19 | 151 | 3 | 4.10.270.10 | |
| Domain | ADH_zinc_N | 4.56e-04 | 19 | 151 | 3 | PF00107 | |
| Domain | ADH_SF_Zn-type | 4.56e-04 | 19 | 151 | 3 | IPR002085 | |
| Domain | ADH_C | 4.56e-04 | 19 | 151 | 3 | IPR013149 | |
| Domain | IQ | 5.05e-04 | 81 | 151 | 5 | SM00015 | |
| Domain | Prot_kinase_dom | GAK ABL1 RPS6KA5 GRK5 WNK1 MYLK2 TLK1 GRK2 GRK3 PRKCA OXSR1 EIF2AK1 | 6.34e-04 | 489 | 151 | 12 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | GAK ABL1 RPS6KA5 GRK5 WNK1 MYLK2 TLK1 GRK2 GRK3 PRKCA OXSR1 EIF2AK1 | 6.80e-04 | 493 | 151 | 12 | PS50011 |
| Domain | ABC_transporter-like | 7.08e-04 | 50 | 151 | 4 | IPR003439 | |
| Domain | EPHD | 7.13e-04 | 22 | 151 | 3 | PS51805 | |
| Domain | IQ_motif_EF-hand-BS | 8.18e-04 | 90 | 151 | 5 | IPR000048 | |
| Domain | GroES-like | 9.26e-04 | 24 | 151 | 3 | IPR011032 | |
| Domain | IQ | 9.49e-04 | 93 | 151 | 5 | PS50096 | |
| Domain | OSR1_C | 9.53e-04 | 6 | 151 | 2 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 9.53e-04 | 6 | 151 | 2 | IPR024678 | |
| Domain | Protein_kinase_ATP_BS | 1.05e-03 | 379 | 151 | 10 | IPR017441 | |
| Domain | AAA | 1.13e-03 | 144 | 151 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.13e-03 | 144 | 151 | 6 | IPR003593 | |
| Domain | Hud_Sxl_RNA | 2.80e-03 | 10 | 151 | 2 | IPR002343 | |
| Domain | Hydrolase_3 | 2.80e-03 | 10 | 151 | 2 | PF08282 | |
| Domain | RGS | 2.80e-03 | 35 | 151 | 3 | PF00615 | |
| Domain | RGS | 2.80e-03 | 35 | 151 | 3 | SM00315 | |
| Domain | - | NUGGC DYNC2H1 RNF112 CFTR RNF213 DNAH7 BLM NLRP14 ABCA6 ABCE1 ERCC6L2 RHOF SMC1B NLRP13 | 2.95e-03 | 746 | 151 | 14 | 3.40.50.300 |
| Domain | RGS | 3.04e-03 | 36 | 151 | 3 | PS50132 | |
| Domain | Spy1 | 3.40e-03 | 11 | 151 | 2 | PF11357 | |
| Domain | Speedy | 3.40e-03 | 11 | 151 | 2 | IPR020984 | |
| Domain | RGS | 3.83e-03 | 39 | 151 | 3 | IPR016137 | |
| Domain | - | 4.59e-03 | 391 | 151 | 9 | 2.30.29.30 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.54e-03 | 14 | 151 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.54e-03 | 14 | 151 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.54e-03 | 14 | 151 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.54e-03 | 14 | 151 | 2 | PF08393 | |
| Domain | P_typ_ATPase_c | 5.54e-03 | 14 | 151 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 5.54e-03 | 14 | 151 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 5.54e-03 | 14 | 151 | 2 | IPR006539 | |
| Domain | MT | 5.54e-03 | 14 | 151 | 2 | PF12777 | |
| Domain | AAA_8 | 5.54e-03 | 14 | 151 | 2 | PF12780 | |
| Domain | PhoLip_ATPase_C | 5.54e-03 | 14 | 151 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 5.54e-03 | 14 | 151 | 2 | PF16209 | |
| Domain | DHC_fam | 6.36e-03 | 15 | 151 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 6.36e-03 | 15 | 151 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.36e-03 | 15 | 151 | 2 | IPR004273 | |
| Domain | ABC_tran | 6.87e-03 | 48 | 151 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 6.87e-03 | 48 | 151 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 7.27e-03 | 49 | 151 | 3 | PS00211 | |
| Domain | PH_dom-like | 7.89e-03 | 426 | 151 | 9 | IPR011993 | |
| Pathway | REACTOME_ABACAVIR_ADME | 2.25e-05 | 8 | 106 | 3 | MM14869 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 4.77e-05 | 10 | 106 | 3 | MM15833 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 6.53e-05 | 11 | 106 | 3 | MM15405 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 8.65e-05 | 12 | 106 | 3 | M14663 | |
| Pubmed | 1.99e-09 | 5 | 157 | 4 | 1316195 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 11960985 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 2474823 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 2737681 | ||
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 9.02e-08 | 3 | 157 | 3 | 23772048 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 8163197 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 9.02e-08 | 3 | 157 | 3 | 24787690 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 3011597 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 6756216 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 37806378 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 7840644 | ||
| Pubmed | Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. | 9.02e-08 | 3 | 157 | 3 | 15670660 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 8018987 | ||
| Pubmed | Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1. | 9.02e-08 | 3 | 157 | 3 | 33586683 | |
| Pubmed | Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. | 9.02e-08 | 3 | 157 | 3 | 3157987 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 2169444 | ||
| Pubmed | A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. | 9.02e-08 | 3 | 157 | 3 | 8486690 | |
| Pubmed | Individual susceptibility and alcohol effects:biochemical and genetic aspects. | 9.02e-08 | 3 | 157 | 3 | 16801720 | |
| Pubmed | Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. | 9.02e-08 | 3 | 157 | 3 | 10424757 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 2347582 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 17326332 | ||
| Pubmed | The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome. | 9.02e-08 | 3 | 157 | 3 | 7748347 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 3006456 | ||
| Pubmed | Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. | 9.02e-08 | 3 | 157 | 3 | 9145544 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 3428612 | ||
| Pubmed | Genetic and developmental regulation of mouse liver alcohol dehydrogenase. | 9.02e-08 | 3 | 157 | 3 | 6816803 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 8973327 | ||
| Pubmed | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 9.02e-08 | 3 | 157 | 3 | 15554233 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 35354963 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 6370228 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 2935875 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF609 FOLH1 KIZ SDCCAG8 TRPM2 APBB2 LAMA3 PHF6 RNF213 CCNG2 KMT2C TLK1 GRK3 GTF3C1 ASMTL USP40 RASGEF1C PDIA5 TANC1 OXSR1 DENND5A CREB3L2 XPO7 | 2.63e-07 | 1489 | 157 | 23 | 28611215 |
| Pubmed | 2.77e-07 | 13 | 157 | 4 | 8948582 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 20357587 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 8813054 | ||
| Pubmed | Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. | 3.60e-07 | 4 | 157 | 3 | 8917529 | |
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 12631290 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 2893758 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 11893554 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 29663519 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 12851412 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 21784156 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 9733106 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 36224745 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 9202249 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 19618839 | ||
| Pubmed | Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. | 3.60e-07 | 4 | 157 | 3 | 3996732 | |
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 9241435 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 10880953 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 8662816 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 9002638 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 15193143 | ||
| Pubmed | ZNF609 TMA16 HIVEP1 HYOU1 MED14 PHF6 SKP1 HNRNPD KMT2C PARP1 TLK1 GTF3C1 CELF1 CELF2 ABCE1 BRD9 CRIPT SMARCE1 DNMT1 | 6.42e-07 | 1103 | 157 | 19 | 34189442 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDLIM7 PKP4 PHF6 DGKD XPC SRBD1 SKP1 HNRNPD ESF1 LRRC47 KIF20A BLM PARP1 GTF2H1 NF1 GTF3C1 ABCE1 PRKCA TANC1 RPL3 DNMT1 | 8.52e-07 | 1353 | 157 | 21 | 29467282 |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 11836246 | ||
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 8621625 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 8.97e-07 | 5 | 157 | 3 | 3829126 | |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 7738026 | ||
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 8.97e-07 | 5 | 157 | 3 | 12919077 | |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 8892527 | ||
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 7026729 | ||
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 10338466 | ||
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 6196357 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 8.97e-07 | 5 | 157 | 3 | 19193628 | |
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 8.97e-07 | 5 | 157 | 3 | 22079585 | |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 10358022 | ||
| Pubmed | MYH2 CTNNAL1 HIVEP1 DYNC2H1 RGPD1 PHF6 XPC DNAH7 FER1L6 ESF1 NF1 ABCE1 SMARCE1 ACSS3 | 1.34e-06 | 638 | 157 | 14 | 31182584 | |
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 17257171 | ||
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 9826657 | ||
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 26807981 | ||
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 1728586 | ||
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 12027900 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.79e-06 | 6 | 157 | 3 | 10077619 | |
| Pubmed | Merging protein, gene and genomic data: the evolution of the MDR-ADH family. | 1.79e-06 | 6 | 157 | 3 | 16121213 | |
| Pubmed | Human liver alcohol dehydrogenase: purification, composition, and catalytic features. | 1.79e-06 | 6 | 157 | 3 | 9982 | |
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 518534 | ||
| Pubmed | Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. | 1.79e-06 | 6 | 157 | 3 | 17185388 | |
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 36451830 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.79e-06 | 6 | 157 | 3 | 10588881 | |
| Pubmed | MYH1 MYH2 MYH8 HYOU1 GRK5 RGPD1 ZBTB41 XPC SRBD1 HNRNPD FER1L6 MYLK2 ESF1 CCDC27 PARP1 TLK1 GTF3C1 KIAA0825 RPL3 RPL3L BBOF1 | 2.33e-06 | 1442 | 157 | 21 | 35575683 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 16685648 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 23456092 | ||
| Pubmed | Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism. | 3.12e-06 | 7 | 157 | 3 | 23468174 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 16047160 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 11784316 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 35210422 | ||
| Pubmed | Androgen regulation of gene expression in primary epithelial cells of the mouse kidney. | 3.12e-06 | 7 | 157 | 3 | 8119157 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 37953328 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 8672451 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 16819597 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 11517230 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TMA16 HIVEP1 XPC SRBD1 MYSM1 KIF20A BLM PARP1 GTF2E1 GTF3C1 BRD9 SMARCE1 DNMT1 | 4.29e-06 | 608 | 157 | 13 | 36089195 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TMA16 HYOU1 RBBP6 PPFIBP1 PKP4 LAMA3 PHF6 SRBD1 SKP1 HNRNPD ESF1 LRRC47 PARP1 GTF2H1 GTF3C1 ALB C9 RPL3 DNMT1 | 4.34e-06 | 1257 | 157 | 19 | 36526897 |
| Pubmed | 4.97e-06 | 8 | 157 | 3 | 7937138 | ||
| Pubmed | 4.97e-06 | 8 | 157 | 3 | 18331377 | ||
| Pubmed | 4.97e-06 | 8 | 157 | 3 | 2040456 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 4.97e-06 | 8 | 157 | 3 | 14667415 | |
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 93520 | ||
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 11747070 | ||
| Pubmed | 1.06e-05 | 10 | 157 | 3 | 1869533 | ||
| Interaction | CDK8 interactions | HIVEP1 MED14 HNRNPD MYSM1 ESF1 PARP1 GTF2E1 GTF3C1 CELF1 MED12L | 7.38e-06 | 222 | 152 | 10 | int:CDK8 |
| Interaction | RPS6KA6 interactions | 1.14e-05 | 67 | 152 | 6 | int:RPS6KA6 | |
| Cytoband | 4q23 | 4.29e-05 | 20 | 157 | 3 | 4q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 2.80e-04 | 37 | 157 | 3 | chr4q23 | |
| GeneFamily | Alcohol dehydrogenases | 1.17e-05 | 8 | 109 | 3 | 397 | |
| GeneFamily | Myosin heavy chains | 9.20e-05 | 15 | 109 | 3 | 1098 | |
| GeneFamily | General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated | 4.45e-04 | 25 | 109 | 3 | 565 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.56e-03 | 206 | 109 | 6 | 682 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 5.29e-06 | 20 | 155 | 4 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 6.51e-06 | 21 | 155 | 4 | MM1102 | |
| Coexpression | KONDO_PROSTATE_CANCER_WITH_H3K27ME3 | 2.12e-05 | 194 | 155 | 8 | M7281 | |
| Coexpression | GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP | 2.64e-05 | 200 | 155 | 8 | M5093 | |
| Coexpression | ZHANG_GATA6_TARGETS_DN | 3.61e-05 | 63 | 155 | 5 | M1778 | |
| Coexpression | ZHANG_GATA6_TARGETS_DN | 4.21e-05 | 65 | 155 | 5 | MM1226 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-07 | 195 | 156 | 8 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.88e-07 | 197 | 156 | 8 | 340ce4fef244176fb52e38ffbcbdfda5ac3467dd | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.71e-06 | 162 | 156 | 7 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-06 | 168 | 156 | 7 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-06 | 168 | 156 | 7 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.44e-06 | 180 | 156 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 4.42e-06 | 187 | 156 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 4.91e-06 | 190 | 156 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.44e-06 | 193 | 156 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-06 | 194 | 156 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.82e-06 | 195 | 156 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 5.82e-06 | 195 | 156 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.82e-06 | 195 | 156 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 196 | 156 | 7 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 6.22e-06 | 197 | 156 | 7 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-06 | 197 | 156 | 7 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(Neuron.Gad1Gad2.Pvalb-Unc5b)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.61e-06 | 79 | 156 | 5 | cc17a013a4a57a99c404b10449ef61ce559631d1 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(Neuron.Gad1Gad2.Pvalb-Unc5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.61e-06 | 79 | 156 | 5 | 19fb2bc964589ea40e7b9f0809c641331c93dacd | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 140 | 156 | 6 | 90298cac4bcec614a48e60b5c139c86daa9f0321 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 140 | 156 | 6 | 671ab1f5cbd8568bf93ebdf961c2a1ede06d2bcb | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.74e-05 | 154 | 156 | 6 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.93e-05 | 169 | 156 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 2.93e-05 | 169 | 156 | 6 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-05 | 170 | 156 | 6 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-05 | 170 | 156 | 6 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.03e-05 | 170 | 156 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 171 | 156 | 6 | d9ad6a3bce3556abd24af1630bf4a99594437c3a | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.23e-05 | 172 | 156 | 6 | 1bbf5ed7d13635f9a7e528060341e0652699bd7c | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.92e-05 | 178 | 156 | 6 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.43e-05 | 182 | 156 | 6 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.71e-05 | 184 | 156 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.86e-05 | 185 | 156 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | remission-CD8+_T_naive|World / disease stage, cell group and cell class | 4.86e-05 | 185 | 156 | 6 | 69304d7dd406ac7e96d51c239d7035a06d88704f | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.00e-05 | 186 | 156 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.00e-05 | 186 | 156 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | severe_influenza-RBC|World / disease group, cell group and cell class (v2) | 5.16e-05 | 187 | 156 | 6 | f846750575f318503d21ade30f5bfd2e1d4c84af | |
| ToppCell | Control-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 5.16e-05 | 187 | 156 | 6 | 3a032432f780525f4f4c2a358897d9989b1ecae7 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.31e-05 | 188 | 156 | 6 | 3638d85452de15a060146628fbbad9d2a36feb13 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.31e-05 | 188 | 156 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pappa_(ventral_GP_(vGP))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.46e-05 | 59 | 156 | 4 | 22f5abf0b7fca1c9b7ce8d1f5e09eebad8937f11 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pappa_(ventral_GP_(vGP))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.46e-05 | 59 | 156 | 4 | 804f6ec763209b2513e7688925136033b41a7b61 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pappa_(ventral_GP_(vGP))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.46e-05 | 59 | 156 | 4 | 025a2df1825fbfa7f37764371dae9296cb9908b6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-05 | 189 | 156 | 6 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.47e-05 | 189 | 156 | 6 | e2bb5900d210386b7b74938e7a3636d0c7ba1bcf | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.63e-05 | 190 | 156 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.63e-05 | 190 | 156 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-05 | 190 | 156 | 6 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.80e-05 | 191 | 156 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.80e-05 | 191 | 156 | 6 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.80e-05 | 191 | 156 | 6 | c72e62cf5b45c04ee5e7719db31f917c4f76b1e4 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.80e-05 | 191 | 156 | 6 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 192 | 156 | 6 | 86d792682ba51696f503c79625dd20f87bcf651f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 192 | 156 | 6 | d0ad6a205ad50a3c523fa68676996b289eabc5de | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.97e-05 | 192 | 156 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-05 | 193 | 156 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 6.14e-05 | 193 | 156 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 193 | 156 | 6 | f597fefc54327a1ad136e2f66b6e81cc5c761eb7 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.32e-05 | 194 | 156 | 6 | 4eef50c38e6edb2ef2cdcd14eb50805f6cd65bc8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-05 | 194 | 156 | 6 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-05 | 194 | 156 | 6 | 0866ab6792cee274a71991d5c37a37f574ff446e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-05 | 194 | 156 | 6 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.32e-05 | 194 | 156 | 6 | 607b5d194ba56efa9b106f10f89368fc103712a0 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.32e-05 | 194 | 156 | 6 | f5367072b259ae170cf0df3d4d871ab41be29d29 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.32e-05 | 194 | 156 | 6 | c45e9d09b5cd6973de6c3f1713b3bf36fa4bfe57 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.50e-05 | 195 | 156 | 6 | 62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.50e-05 | 195 | 156 | 6 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.50e-05 | 195 | 156 | 6 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.50e-05 | 195 | 156 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.50e-05 | 195 | 156 | 6 | cab90c67a7b3119c0d0d2d5e84511c41dcb8765f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.50e-05 | 195 | 156 | 6 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 6.50e-05 | 195 | 156 | 6 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_ACKR1+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.88e-05 | 197 | 156 | 6 | 143607d195c8aa2b94d995af0b2ef38582565611 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.88e-05 | 197 | 156 | 6 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.88e-05 | 197 | 156 | 6 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.88e-05 | 197 | 156 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 6.88e-05 | 197 | 156 | 6 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.88e-05 | 197 | 156 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.88e-05 | 197 | 156 | 6 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.88e-05 | 197 | 156 | 6 | 57dafb3047745a44b2345b8036e159c3641d496e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.88e-05 | 197 | 156 | 6 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.88e-05 | 197 | 156 | 6 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | 3'-Adult|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-05 | 198 | 156 | 6 | 302adb42089ff22fffc4f01af572ca2e151f7ce7 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.07e-05 | 198 | 156 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | COVID-19-kidney-Macrophages|kidney / Disease (COVID-19 only), tissue and cell type | 7.07e-05 | 198 | 156 | 6 | 161324541fe5da5cbb58142ea94fefd39b7dfb04 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 199 | 156 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.48e-05 | 200 | 156 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.48e-05 | 200 | 156 | 6 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | 7.48e-05 | 200 | 156 | 6 | 65ae349fac4084faacbc6a645a92398f6324770e | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.48e-05 | 200 | 156 | 6 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.50e-05 | 127 | 156 | 5 | cd69ba386796715e87674f8324d2acaad1d4d094 | |
| ToppCell | RV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.09e-04 | 134 | 156 | 5 | 8c4046ba1f85172915a112499e492c3efe8474c2 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2-Excitatory_Neuron.Slc17a7-Slc17a6.Fezf2-Htr2c_(Layer_5,_Retrosplenial_cortex_(RSG)_and_Subiculum,_Tshz2+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.40e-04 | 75 | 156 | 4 | f225f053d899db133d50e878e8ec04f2a149b93c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_Hsd17b2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.62e-04 | 78 | 156 | 4 | e5dbb0986cbee58fb1e5e464a3b003c4136246e7 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 1.64e-04 | 146 | 156 | 5 | 1cb2e157222631e8915d89b255a843d16d7d99cc | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.16e-04 | 155 | 156 | 5 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 157 | 156 | 5 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 157 | 156 | 5 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.36e-04 | 158 | 156 | 5 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.36e-04 | 158 | 156 | 5 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-04 | 158 | 156 | 5 | b35bab2b93d0af821bfae18a358eb7dddaf3860f | |
| Drug | 4-Iodopyrazole | 3.22e-07 | 3 | 157 | 3 | DB02721 | |
| Drug | 1,5-AG | 5.65e-07 | 182 | 157 | 10 | CID000064960 | |
| Drug | Fomepizole | 1.28e-06 | 4 | 157 | 3 | DB01213 | |
| Drug | willardine | 2.53e-06 | 32 | 157 | 5 | CID000005123 | |
| Drug | H-9 dihydrochloride | 3.00e-06 | 90 | 157 | 7 | CID000003544 | |
| Drug | 3-hydroxyvalerate | 7.78e-06 | 19 | 157 | 4 | CID000107802 | |
| Drug | Ethanol | 1.10e-05 | 7 | 157 | 3 | DB00898 | |
| Drug | 4-iodopyrazole | 1.19e-05 | 21 | 157 | 4 | CID000077022 | |
| Drug | I-Q-S | 1.31e-05 | 156 | 157 | 8 | CID000003540 | |
| Drug | N-heptylformamide | 1.76e-05 | 8 | 157 | 3 | CID000347402 | |
| Drug | 2-butoxyethanol | 2.08e-05 | 24 | 157 | 4 | CID000008133 | |
| Drug | 2-NA | 2.62e-05 | 9 | 157 | 3 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 2.62e-05 | 9 | 157 | 3 | CID000440672 | |
| Drug | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone | 4.28e-05 | 184 | 157 | 8 | ctd:C576882 | |
| Drug | 12-bromolaurate | 4.59e-05 | 57 | 157 | 5 | CID000175468 | |
| Drug | Trichodermamide B | 4.72e-05 | 2 | 157 | 2 | CID000639644 | |
| Drug | 13,14-dihydro-15-keto-prostaglandin A2 | 4.72e-05 | 2 | 157 | 2 | CID003881016 | |
| Drug | 9-anthroic acid | 4.72e-05 | 2 | 157 | 2 | ctd:C010030 | |
| Drug | AC1L1IZ2 | 5.17e-05 | 304 | 157 | 10 | CID000004795 | |
| Drug | NSC107658 | 5.46e-05 | 306 | 157 | 10 | CID000002919 | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; HL60; HG-U133A | 6.22e-05 | 194 | 157 | 8 | 1715_DN | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 7346_UP | |
| Drug | AC1L1J0I | 6.76e-05 | 12 | 157 | 3 | CID000030201 | |
| Drug | hexa-2,4-dien-1-ol | 6.76e-05 | 12 | 157 | 3 | CID000008104 | |
| Drug | sulindac sulfide; Down 200; 50uM; MCF7; HG-U133A | 6.93e-05 | 197 | 157 | 8 | 308_DN | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.60e-05 | 10 | 153 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.60e-05 | 10 | 153 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.60e-05 | 10 | 153 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.60e-05 | 10 | 153 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.60e-05 | 10 | 153 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.60e-05 | 10 | 153 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.60e-05 | 10 | 153 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.60e-05 | 10 | 153 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 1.71e-05 | 30 | 153 | 4 | DOID:14330 (biomarker_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.91e-05 | 12 | 153 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.91e-05 | 12 | 153 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.76e-05 | 13 | 153 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 5.94e-05 | 15 | 153 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | liver cirrhosis (is_marker_for) | 6.94e-05 | 82 | 153 | 5 | DOID:5082 (is_marker_for) | |
| Disease | myopathy (implicated_via_orthology) | 1.13e-04 | 48 | 153 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Inherited acute myeloid leukemia | 1.59e-04 | 4 | 153 | 2 | C4707228 | |
| Disease | hereditary sensory neuropathy (is_implicated_in) | 1.59e-04 | 4 | 153 | 2 | DOID:0050548 (is_implicated_in) | |
| Disease | alcohol dependence measurement | 1.93e-04 | 55 | 153 | 4 | EFO_0007835 | |
| Disease | Immunologic Deficiency Syndromes | 2.24e-04 | 23 | 153 | 3 | C0021051 | |
| Disease | Alcohol dependence | 2.64e-04 | 5 | 153 | 2 | cv:C0001973 | |
| Disease | ALCOHOL DEPENDENCE | 2.64e-04 | 5 | 153 | 2 | 103780 | |
| Disease | cholestasis (is_marker_for) | 2.64e-04 | 5 | 153 | 2 | DOID:13580 (is_marker_for) | |
| Disease | Azoospermia | 2.64e-04 | 5 | 153 | 2 | C0004509 | |
| Disease | Carcinoma, Granular Cell | 3.54e-04 | 116 | 153 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.54e-04 | 116 | 153 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.54e-04 | 116 | 153 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.54e-04 | 116 | 153 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.54e-04 | 116 | 153 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 3.54e-04 | 116 | 153 | 5 | C0001418 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 4.52e-04 | 29 | 153 | 3 | C1274933 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 4.52e-04 | 29 | 153 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 4.52e-04 | 29 | 153 | 3 | C3658302 | |
| Disease | Toxic Epidermal Necrolysis | 4.52e-04 | 29 | 153 | 3 | C0014518 | |
| Disease | Non-alcoholic Fatty Liver Disease | 4.88e-04 | 70 | 153 | 4 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 4.88e-04 | 70 | 153 | 4 | C3241937 | |
| Disease | Stevens-Johnson Syndrome | 5.01e-04 | 30 | 153 | 3 | C0038325 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 5.16e-04 | 71 | 153 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 5.24e-04 | 352 | 153 | 8 | EFO_0007014 | |
| Disease | bitter alcoholic beverage consumption measurement | 6.62e-04 | 133 | 153 | 5 | EFO_0010092 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 7.27e-04 | 34 | 153 | 3 | EFO_0009926 | |
| Disease | Cardiovascular Diseases | 8.61e-04 | 36 | 153 | 3 | C0007222 | |
| Disease | congestive heart failure (is_marker_for) | 8.88e-04 | 82 | 153 | 4 | DOID:6000 (is_marker_for) | |
| Disease | alcohol use disorder measurement | 9.04e-04 | 214 | 153 | 6 | EFO_0009458 | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 9.33e-04 | 37 | 153 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | colorectal carcinoma (is_marker_for) | 9.33e-04 | 37 | 153 | 3 | DOID:0080199 (is_marker_for) | |
| Disease | glutamate carboxypeptidase 2 measurement | 9.39e-04 | 9 | 153 | 2 | EFO_0020408 | |
| Disease | IGF-1 measurement | 1.05e-03 | 488 | 153 | 9 | EFO_0004627 | |
| Disease | Colorectal Carcinoma | FOLH1 CFTR WNK1 ADH1B LRRC47 KMT2C PARP1 NF1 ABCA6 ABCE1 ZNF624 | 1.13e-03 | 702 | 153 | 11 | C0009402 |
| Disease | gait measurement | 1.14e-03 | 150 | 153 | 5 | EFO_0007680 | |
| Disease | X-21448 measurement | 1.17e-03 | 10 | 153 | 2 | EFO_0800816 | |
| Disease | complement factor D measurement | 1.42e-03 | 93 | 153 | 4 | EFO_0020283 | |
| Disease | Ashkenazi Jewish disorders | 1.42e-03 | 11 | 153 | 2 | cv:CN118946 | |
| Disease | social interaction measurement | 1.48e-03 | 94 | 153 | 4 | EFO_0009592 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 1.66e-03 | 97 | 153 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | middle cerebral artery infarction (is_implicated_in) | 1.70e-03 | 12 | 153 | 2 | DOID:3525 (is_implicated_in) | |
| Disease | Intestinal Neoplasms | 1.70e-03 | 12 | 153 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 1.70e-03 | 12 | 153 | 2 | C0346627 | |
| Disease | neurotic disorder | 1.92e-03 | 101 | 153 | 4 | EFO_0004257 | |
| Disease | Alzheimer's disease biomarker measurement | 1.99e-03 | 48 | 153 | 3 | EFO_0006514 | |
| Disease | alcohol and nicotine codependence | 2.01e-03 | 13 | 153 | 2 | EFO_0004776 | |
| Disease | Coffin-Siris syndrome | 2.01e-03 | 13 | 153 | 2 | C0265338 | |
| Disease | alcohol consumption measurement | CTTNBP2 RPS6KA5 SDCCAG8 GRM3 ADH1A ADH1B ADH1C CYRIA NF1 CELF1 C19orf12 ACSS3 PHACTR1 CCSER1 XPO7 | 2.07e-03 | 1242 | 153 | 15 | EFO_0007878 |
| Disease | Leukemia, Myelocytic, Acute | 2.13e-03 | 173 | 153 | 5 | C0023467 | |
| Disease | immature platelet count | 2.29e-03 | 106 | 153 | 4 | EFO_0803544 | |
| Disease | breastfeeding duration | 2.33e-03 | 14 | 153 | 2 | EFO_0006864 | |
| Disease | pulmonary emphysema (is_marker_for) | 2.33e-03 | 14 | 153 | 2 | DOID:9675 (is_marker_for) | |
| Disease | Heschl's gyrus morphology measurement | 2.65e-03 | 53 | 153 | 3 | EFO_0005852 | |
| Disease | mannan-binding lectin serine protease 1 measurement | 2.68e-03 | 15 | 153 | 2 | EFO_0008223 | |
| Disease | non-dense area measurement, mammographic density measurement | 2.68e-03 | 15 | 153 | 2 | EFO_0005941, EFO_0006504 | |
| Disease | Hepatitis | 2.68e-03 | 15 | 153 | 2 | C0019158 | |
| Disease | neuroticism measurement | MYH2 ZNF609 HIVEP1 CTTNBP2 PKP4 PHF6 GRM3 CELF1 CELF2 PRKCA ACSS3 CCSER1 | 2.85e-03 | 909 | 153 | 12 | EFO_0007660 |
| Disease | leukemia | 2.94e-03 | 55 | 153 | 3 | C0023418 | |
| Disease | alcohol use disorder (is_implicated_in) | 3.06e-03 | 16 | 153 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | isoleucine measurement | 3.10e-03 | 56 | 153 | 3 | EFO_0009793 | |
| Disease | birth weight, parental genotype effect measurement | 3.33e-03 | 192 | 153 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | Moyamoya Disease | 3.45e-03 | 17 | 153 | 2 | C0026654 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 3.45e-03 | 17 | 153 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.56e-03 | 195 | 153 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Brain Ischemia | 3.77e-03 | 60 | 153 | 3 | C0007786 | |
| Disease | Cerebral Ischemia | 3.77e-03 | 60 | 153 | 3 | C0917798 | |
| Disease | ischemia (biomarker_via_orthology) | 3.87e-03 | 18 | 153 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | migraine disorder, systolic blood pressure | 3.87e-03 | 18 | 153 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | Bone marrow hypocellularity | 3.87e-03 | 18 | 153 | 2 | C1855710 | |
| Disease | body fat percentage | 4.06e-03 | 488 | 153 | 8 | EFO_0007800 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 4.31e-03 | 19 | 153 | 2 | EFO_0002609, GO_0031427 | |
| Disease | Adenocarcinoma of lung (disorder) | 4.49e-03 | 206 | 153 | 5 | C0152013 | |
| Disease | maximal midexpiratory flow rate | 4.77e-03 | 20 | 153 | 2 | EFO_0004313 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 4.96e-03 | 301 | 153 | 6 | DOID:684 (is_marker_for) | |
| Disease | venous thromboembolism, fibrinogen measurement | 5.14e-03 | 67 | 153 | 3 | EFO_0004286, EFO_0004623 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVKMEVCRLGGIKHL | 561 | Q99569 | |
| CLDKKRIKMKQGETL | 221 | P35626 | |
| DRKLFIGMVSKKCNE | 131 | O95319 | |
| KLLCSLSGERKMKAA | 21 | Q9NSK7 | |
| KVGSKCCKHPEAKRM | 456 | P02768 | |
| SKIMAERKNAKALAC | 546 | Q92870 | |
| KQLMCLARSVLSKAK | 1351 | P13569 | |
| MEKACKRDVKETIGA | 1821 | Q68DQ2 | |
| KAIGLEIKLCMLAKA | 1586 | P26358 | |
| AKKSKKPSREVISCM | 266 | Q9H8M2 | |
| MSTAGKVIKCKAAVL | 1 | P07327 | |
| PEKICIRKKCASMVH | 616 | O43506 | |
| EDRKLFIGMISKKCT | 106 | Q92879 | |
| MSTAGKVIKCKAAVL | 1 | P00325 | |
| MSTAGKVIKCKAAVL | 1 | P00326 | |
| TKLCDAMKILDGKKL | 416 | Q14832 | |
| VFVLRCMELKCGKKR | 1211 | Q8N139 | |
| CKCTASDIKRMEKII | 131 | Q16589 | |
| AKLDKLVKLCSGMVE | 31 | Q96P50 | |
| VDRDAKKLNKACKGM | 16 | P27216 | |
| MKNCGKIHLKRTKLD | 361 | O60423 | |
| QDCTAVKTLLLKMKR | 626 | Q9C0I3 | |
| SRMAQKEKELCIGRK | 56 | Q9UIA0 | |
| KEKELCIGRKKFNMD | 61 | Q9UIA0 | |
| DKLVKLCIAMIDTGK | 36 | Q15057 | |
| GVTETLKKKRLMFCQ | 951 | Q9P1Z9 | |
| KEKVLRLLFAKMNGC | 446 | Q8ND07 | |
| KQGLRTLCIAKKVMS | 836 | Q9P241 | |
| RIKDMEKQKKEGIVC | 746 | Q76M96 | |
| CLDKKRIKMKQGETL | 221 | P25098 | |
| EREALKMQLKCLLKG | 261 | Q2M243 | |
| KKSSTKLRMDTCLQK | 86 | Q7Z5L2 | |
| KGCMEKIEKGQVRLS | 126 | P09874 | |
| GKSFRKMISLCLQKD | 261 | O95747 | |
| NCISKIEGISKMTKL | 941 | Q6ZRR7 | |
| LAMKAKCKLTICPEE | 326 | Q9UM07 | |
| SKIDMKGCIKVLKEQ | 276 | Q9H0Q0 | |
| KILEPVACVRKKSEM | 4636 | Q8NEZ4 | |
| RMSVNCEKLVKREKP | 676 | Q86YW9 | |
| GCMKNLKKTSGVVRL | 2736 | Q16787 | |
| KKIGKFCSDIMEKLD | 481 | Q8IV33 | |
| KRLQEKLVCKMKGEG | 281 | Q86W92 | |
| RKSLMDIIGKLQKCT | 1021 | Q9Y6X6 | |
| NKCATCKMILEKEAK | 61 | Q9NQ38 | |
| CKMILEKEAKSQKRA | 66 | Q9NQ38 | |
| KTHGNKCTMCKEKLE | 801 | Q9NQ38 | |
| KLRDKRLEKMVSGCQ | 236 | Q8N1G4 | |
| MLSKGLLTACKLKVF | 296 | O95671 | |
| FKLERDMKINCSGKI | 186 | Q04609 | |
| RKGKKTLVCEMCAVI | 1656 | Q8IVV2 | |
| LDNSIGIKKMKTSCK | 131 | Q9H501 | |
| RLKKCFRAGMKKEAV | 116 | P41235 | |
| ISKAKGNLEKMCRSL | 1241 | P13535 | |
| KRKVISLKGCLTQMF | 86 | Q8NH49 | |
| CSKAIKIFMGRTELK | 916 | Q02817 | |
| KAKGNLEKMCRTLED | 1246 | Q9UKX2 | |
| TCMEKATGLKLAAKV | 301 | Q9H1R3 | |
| VPSVKRMKKCLKGIS | 631 | A8MYU2 | |
| CTSAVEIMKKIKKGD | 631 | O75582 | |
| TVSKAKGNLEKMCRA | 1241 | P12882 | |
| DLGEKQKALKMILTC | 221 | Q9BXC1 | |
| MKCVKSRKDEIKQAL | 91 | Q9NX08 | |
| QIKKMLCSKDSLGLK | 111 | Q2M2Z5 | |
| CAKCKKKITGEIMHA | 341 | Q9NR12 | |
| LCDLKKQIMGREKLK | 26 | Q7Z6E9 | |
| KQIMGREKLKAADCD | 31 | Q7Z6E9 | |
| CPVESKKTKRAGEMC | 621 | O60244 | |
| MKVCRKDSLAIKLSN | 416 | Q9C0D0 | |
| GVSSKSMKELKELCK | 336 | Q8IZJ4 | |
| CKGQLVEFLKKMESR | 126 | O14976 | |
| MLRAALCKTGKVVKQ | 1991 | Q8NCM8 | |
| KKSCPVVRMGKLCIE | 26 | P61221 | |
| ATKGKEMDCLKNGLR | 356 | Q8IU89 | |
| TVMLKEKLAELRKLC | 791 | Q9Y4L1 | |
| EKEMKKLRAELRKSC | 426 | B1AJZ9 | |
| AKVSQREEMVKKCLG | 1206 | P54132 | |
| KAKMAAARAVLEKCT | 221 | Q9UBT7 | |
| KGATKTVCMKVLREV | 201 | Q9BQI3 | |
| SKACLKKIRMLVAEN | 251 | O95273 | |
| VLMLVKECKQLSGKV | 171 | Q8WZ74 | |
| ASMIGAKCKKLRTLD | 471 | Q9UKA2 | |
| MVCEKCEKKLGTVIT | 1 | Q9P021 | |
| EIIATMKKKGEKRCL | 61 | P02778 | |
| VKRADIICGKLLAKM | 561 | Q8WXX0 | |
| MLEICLKLVGCKSKK | 1 | P00519 | |
| VEGLLKECRNKTKRM | 751 | Q6IQ26 | |
| LKKKVTRDMICAGEK | 621 | P48740 | |
| KVGHMKRILCGIKEL | 1191 | Q16760 | |
| CLLKKMEIKGEQISK | 366 | Q8IYX8 | |
| TSKIDMKGCIKVLKD | 276 | Q9NUQ9 | |
| VLMEKLCKKGLAATT | 471 | Q9HB96 | |
| DVKDVMGLKCITLKG | 3801 | Q8NDH2 | |
| PKARVTEVMKALKCN | 291 | Q5T890 | |
| AKSICKMLLTKDAKQ | 416 | P34947 | |
| LASGAVSVMKKCRKL | 471 | O60779 | |
| VSVMKKCRKLEDPQS | 476 | O60779 | |
| KCRKILTKMKQQGHE | 186 | P0C7I6 | |
| SMKRKGVELKDIKRC | 366 | P02748 | |
| KLQTLVMGKVSRTCK | 356 | Q70SY1 | |
| GDAESRKLCKKMKVD | 86 | Q14554 | |
| DKVKEALRDGMKRCC | 291 | Q8NGT5 | |
| LRKMICQEVKAITKL | 801 | P0DJD0 | |
| KKMKAENTRLCTKAL | 946 | Q8TBY8 | |
| NVGLSKCEIKVAMSK | 246 | Q14103 | |
| KCDISVMGKGDVLKT | 201 | Q2WGJ9 | |
| LKGDKFIKCRMRVET | 66 | P29083 | |
| MVLIGCKTDLRKDKE | 126 | Q9HBH0 | |
| QITGKKACERMKDAI | 676 | Q68CJ6 | |
| GLVKEINRCEKVKTM | 291 | Q9HCM9 | |
| KRLCGLKVEVDMEKI | 271 | Q969G3 | |
| LSKEAVSVCKGLMTK | 561 | P17252 | |
| SLATVKMKECLRGKL | 331 | Q6UWF7 | |
| SFCGKTKMKRRAVKI | 41 | A6NKH3 | |
| VMLKGCVVGTKKRVL | 331 | P39023 | |
| VMLKGCIAGTKKRVI | 331 | Q92901 | |
| VKFCKEELSGMKNKI | 136 | Q86SQ7 | |
| ALKKLKGVCVRLSMG | 196 | Q86UD5 | |
| MKLVCLLTKKGVRVD | 981 | Q9C0D5 | |
| TIQKIKKEGKMSECL | 281 | Q8N5C6 | |
| MQKLKARCLGNIVVK | 491 | Q9H6R3 | |
| LKAGALAIEKCKVMA | 791 | P48736 | |
| KKEKRCVDSLLKMCG | 1151 | Q63HN8 | |
| RLNKCISMSKKLLIE | 266 | Q9UKI8 | |
| CAKIDEKGLKTMVSL | 246 | P32780 | |
| IICKEMKGSKAIRQT | 246 | Q9P2J8 | |
| KTVLQEIKRGKRMKC | 266 | Q8IWS0 | |
| GKCVKMQILGSTLKL | 111 | Q8N2B8 | |
| GRKVSCMKSALLLKG | 156 | A4D1E1 | |
| MKICKIKNLSGSSEI | 1551 | Q9BX84 | |
| EFLSRKGLKKTCVTM | 16 | Q4G0A6 | |
| CKQKRGLRSLGEKMK | 101 | Q9ULX5 | |
| RELKGCKMVIDVIKT | 586 | Q8NDV3 | |
| ALQTVCLKGTKVHMK | 66 | P05452 | |
| MVLVKLDLRKKAACI | 796 | O95235 | |
| VETLCGLKMKLKQQR | 96 | A0A494C086 | |
| GAICRKSIKKMLEVL | 1361 | O94759 | |
| LVATEICMPAKKKQR | 261 | Q8N431 | |
| PKANTKVICKRCKVM | 201 | Q7Z6J8 | |
| KVICKRCKVMLGETV | 206 | Q7Z6J8 | |
| DVCKKIFKGKSSLEM | 671 | Q5SVQ8 | |
| VETLCGLKMKLKQQR | 56 | Q8NFV5 | |
| ENECRLLKKVKSEKM | 236 | O15014 | |
| VSSKVIGRMCKIIDK | 2046 | P21359 | |
| VTLGENSRKKMKDCK | 21 | Q8IYM2 | |
| LDVTCKTVANMIKGK | 116 | P63208 | |
| VAEKMEKRTCALCPK | 36 | Q9UIL8 | |
| LLLRKGCKNVDEFKM | 111 | Q6ZMV8 | |
| SMCGKAFIKKSQLII | 266 | Q2M218 | |
| ALKLKGISICFSMLK | 826 | Q9UIA9 | |
| CAKEAAILGKKVMVL | 171 | Q86VQ6 | |
| VKGKKCIVLVTELMT | 291 | Q9H4A3 | |
| KKMCSDGEKAEKRSI | 511 | Q01831 | |
| KTKKGTDVMVRCLKL | 321 | Q12789 | |
| RLTSCLKKREEMKLK | 11 | Q9Y275 | |
| ISVRDCLKLMLKKSG | 866 | Q9NVE5 | |
| EECGIRCKKPSMLKK | 2091 | P15822 | |
| KILLAAMCLVTKGEK | 581 | O95932 | |
| AMCLVTKGEKLLVEK | 586 | O95932 | |
| KLCEDAVLNKKLMRK | 126 | O75795 | |
| IKMRKICANDAIPKT | 156 | Q96EY4 | |
| ITEEKVCMVCKKKIG | 846 | Q96JC1 | |
| LCELKPKDLGMKSKT | 311 | A6PVS8 | |
| DTDGVKMLCKALKKS | 1021 | Q86W25 | |
| LKIFGKMNLKDLCER | 76 | Q86W24 | |
| KLLECMRKTLSKVTN | 776 | Q5VVJ2 |